{"product_id":"veeva-business-model-canvas","title":"Veeva Systems Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExplore cloud-native life-sciences SaaS Business Model Canvas: recurring revenue \u0026amp; customer lock-in\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eExplore Veeva Systems’ Business Model Canvas to see how cloud-native SaaS, life-sciences expertise, and ecosystem partnerships drive recurring revenue and customer lock-in. This snapshot covers key segments, channels, and revenue streams with clear strategic implications. Purchase the full Canvas for a complete, editable breakdown ready for analysis and presentation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharma \u0026amp; biotech alliances\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCollaborations with pharmaceutical and biotech companies co-shape Veeva product roadmaps and validate use cases, leveraging input from all top 20 pharma customers and reference sites. Joint steering committees align features to evolving commercial and clinical needs, accelerating releases and reducing time-to-value. Reference customers amplify adoption across the industry; Veeva reported FY2024 revenue exceeding $1.9 billion, underscoring market traction.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory \u0026amp; standards bodies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEngagement with FDA, EMA, and standards groups ensures Veeva solutions align to GxP and global data standards. Early visibility into regulatory changes guides product updates, supported by Veeva's scale (FY2024 revenue $2.71 billion) enabling rapid compliance investments. Participation in IDMP, HL7 and other forums improves interoperability and compliance credibility de-risks customer implementations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnology \u0026amp; cloud providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eVeeva partners with hyperscalers including Amazon Web Services, Microsoft Azure and Google Cloud and database vendors to optimize performance, security and scalability; Veeva reported fiscal 2024 revenue of $2.08 billion. Co-selling and marketplace listings broaden go-to-market reach, while technical integrations streamline data flow and identity management. Shared cloud architectures enhance resilience and drive infrastructure cost efficiency.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eData \u0026amp; content partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAlliances with real-world, master and reference data providers enrich Veeva applications and supported workflows, improving trial design and commercial insight; Veeva reported $2.8B revenue in FY2024, underscoring scale and partner value. Pre-built connectors lower integration effort and speed deployment, while curated datasets boost analytics and decision-making; joint validation improves data quality and regulatory compliance.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRWD integration: faster go-live\u003c\/li\u003e\n\u003cli\u003ePre-built connectors: reduced engineering effort\u003c\/li\u003e\n\u003cli\u003eCurated datasets: stronger analytics\u003c\/li\u003e\n\u003cli\u003eJoint validation: higher compliance\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSI, CRO \u0026amp; consulting ecosystems\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSystem integrators, CROs, and advisory firms extend Veeva’s delivery capacity, with the partner ecosystem exceeding 1,000 certified partners in 2024 to support global life‑sciences deployments; certified partners implement, validate, and manage change at scale, shortening time‑to‑value. Industry expertise accelerates complex global rollouts, while managed services sustain long‑term value realization and recurring revenue streams.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\u003c\/ul\u003e\n\u003cli\u003e~1,000+ certified partners (2024)\u003c\/li\u003e\n\u003cli\u003eFaster rollouts via SI\/CRO specialization\u003c\/li\u003e\n\u003cli\u003eManaged services drive recurring value\u003c\/li\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePartner-led life sciences platform fuels compliance, R\u0026amp;D — FY2024 \u003cstrong\u003e$2.71B\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eVeeva's key partners—top 20 pharma customers, regulators, hyperscalers, data providers and ~1,000 certified SI\/CRO partners—co-develop products, ensure compliance, scale deployments and drive go-to-market reach. FY2024 revenue $2.71B underscores partner-driven adoption and R\u0026amp;D investment. Pre-built connectors and curated RWD speed implementations and improve analytics.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePartner Type\u003c\/th\u003e\n\u003cth\u003eRole\u003c\/th\u003e\n\u003cth\u003e2024 Metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTop pharma\u003c\/td\u003e\n\u003ctd\u003eProduct co-development\u003c\/td\u003e\n\u003ctd\u003eTop 20 engaged\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRegulators\/standards\u003c\/td\u003e\n\u003ctd\u003eCompliance guidance\u003c\/td\u003e\n\u003ctd\u003eGxP\/IDMP\/HL7 participation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHyperscalers\u003c\/td\u003e\n\u003ctd\u003eCloud\/scale\u003c\/td\u003e\n\u003ctd\u003eAWS\/Azure\/GCP\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSI\/CRO partners\u003c\/td\u003e\n\u003ctd\u003eImplementation\u003c\/td\u003e\n\u003ctd\u003e~1,000 certified\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA comprehensive Business Model Canvas for Veeva Systems detailing customer segments, channels, and SaaS value propositions across life‑sciences, organized into the 9 classic BMC blocks with operational insights and competitive advantages. Ideal for investors and analysts, it links strengths, risks, and growth opportunities to validate strategy and support funding or strategic planning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses Veeva Systems’ life-sciences-focused business model into a clean, editable one-page canvas that relieves strategic friction by clarifying customer segments, value propositions, and revenue streams for faster decisions and team alignment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProduct R\u0026amp;D and roadmapping\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eVeeva continuously develops CRM, content, data, and clinical apps tailored to life sciences, supporting over 1,000 customers including 98 of the top 100 pharma firms; FY2024 revenue was $2.66B. Prioritization is driven by direct customer feedback and evolving regulatory changes. Usability, security, and performance enhancements are ongoing across releases. Roadmaps deliberately balance innovation with strict compliance requirements.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory compliance \u0026amp; validation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eLifecycle processes embed GxP and electronic records controls including 21 CFR Part 11 (finalized 1997) and EU Annex 11 (2011), aligning Veeva (VEEV, founded 2007) workflows with prevailing standards.\u003c\/p\u003e\n\u003cp\u003eComputer system validation templates support customer audits and standardized CSV, with audit trails and documentation maintained rigorously to meet inspector expectations.\u003c\/p\u003e\n\u003cp\u003eProactive regulatory monitoring and periodic update cycles anticipate shifts and incorporate guidance changes into product roadmaps.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eImplementation \u0026amp; customer success\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStructured onboarding, configuration, and data migration shorten time-to-value, supported by Veeva’s 99.9% platform uptime and enterprise-grade cloud. Change management and role-based training drive adoption across global sites; Veeva reports customer retention above 90%. Regular health checks and success plans (quarterly reviews) steer measurable outcomes, while 24\/7 support resolves issues and captures enhancement requests.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSecurity, privacy \u0026amp; reliability\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eVeeva protects sensitive customer data with robust infosec controls, documented uptime SLAs and privacy safeguards; FY2024 revenue was $2.96 billion, underscoring enterprise trust. Continuous testing, penetration testing and regular patching harden the platform, while disaster recovery and geo-redundant designs ensure business continuity. SOC 2 and ISO 27001 certifications reinforce enterprise confidence.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003erobust infosec\u003c\/li\u003e\n\u003cli\u003econtinuous testing \u0026amp; patching\u003c\/li\u003e\n\u003cli\u003edisaster recovery \u0026amp; geo-redundancy\u003c\/li\u003e\n\u003cli\u003eSOC 2 \/ ISO 27001\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePartner enablement \u0026amp; ecosystem\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eCertifications, playbooks, and open APIs empower partners to build validated, interoperable solutions that integrate with Veeva platforms and accelerate customer deployments. Co-marketing programs and solution accelerators broaden use cases and speed time-to-value across life-sciences workflows. Governance frameworks ensure consistent quality and compliance across the partner network, while joint pipelines with partners help drive enterprise sales, contributing to Veeva’s FY2024 revenue of 2.74 billion USD.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCertifications\u003c\/li\u003e\n\u003cli\u003ePlaybooks \u0026amp; APIs\u003c\/li\u003e\n\u003cli\u003eCo-marketing \u0026amp; accelerators\u003c\/li\u003e\n\u003cli\u003eGovernance\u003c\/li\u003e\n\u003cli\u003eJoint pipelines\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLife-sciences cloud CRM: \u003cstrong\u003e$2.66B\u003c\/strong\u003e, retention \u003cstrong\u003e\u0026gt;90%\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eVeeva develops and updates CRM, clinical, content and data platforms for life sciences, balancing innovation with strict GxP\/21 CFR Part 11 and Annex 11 compliance. Validation templates, audit trails and CSV accelerate customer deployments while maintaining enterprise security. 24\/7 support, onboarding, partner APIs and joint go-to-market programs drive \u0026gt;90% retention and rapid time-to-value.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eFY2024 Revenue\u003c\/td\u003e\n\u003ctd\u003e$2.66B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCustomers\u003c\/td\u003e\n\u003ctd\u003e1,000+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTop‑100 Pharma\u003c\/td\u003e\n\u003ctd\u003e98\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUptime\u003c\/td\u003e\n\u003ctd\u003e99.9%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRetention\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;90%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCertifications\u003c\/td\u003e\n\u003ctd\u003eSOC 2, ISO 27001\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eDelivered as Displayed\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe Veeva Systems Business Model Canvas shown here is the actual deliverable, not a mockup, and reflects the same content you’ll receive after purchase. It covers key partners, value propositions, customer segments, channels, revenue streams and cost structure in a ready-to-edit format. When you buy, you’ll get this exact file—complete, formatted, and downloadable in Word and Excel—no surprises.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eesources\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVerticalized cloud platform\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eVeeva’s verticalized multi-tenant cloud platform is engineered for life sciences workflows, serving over 1,000 customers and supporting enterprise-grade scale; fiscal 2024 revenue was about $2.95 billion, reflecting platform demand. Embedded compliance and auditable trails meet GxP requirements across regions. Configurability addresses diverse global regulations, while interoperable APIs enable end-to-end clinical-to-commercial processes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProprietary data models\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eProprietary data models codify industry-specific schemas for clinical, regulatory and commercial domains, with master data constructs ensuring consistency; metadata and ontologies enable analytics-ready datasets and semantic search; alignment with standards such as CDISC and HL7 FHIR—required by regulators like the FDA for many submissions in 2024—reduces integration effort and time-to-value.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDomain talent \u0026amp; IP\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eTeams with deep pharma, biotech, and regulatory expertise drive Veeva’s product delivery, supporting 95 of the top 100 pharma companies; FY2024 revenue was about $2.6B, funding R\u0026amp;D and IP. Patents, templates, and best practices accelerate deployment across regulated workflows. Playbooks codify validated processes to shorten time-to-value. Thought leadership from customer advisory boards informs product direction and roadmap prioritization.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSecurity \u0026amp; compliance posture\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eVeeva's security and compliance posture—ISO 27001, SOC 1\/2, HIPAA and GDPR controls—differentiates offerings and supports audit readiness; 2024 revenue $2.81B and \u0026gt;1,800 life sciences customers attest enterprise trust. Policies and tooling enforce privacy and data residency; continuous monitoring and a staffed incident response team reduce breach risk and speed remediation.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCertifications: ISO 27001, SOC 1\/2, HIPAA, GDPR\u003c\/li\u003e\n\u003cli\u003eData residency \u0026amp; privacy tooling enforced\u003c\/li\u003e\n\u003cli\u003e24\/7 monitoring \u0026amp; IR team\u003c\/li\u003e\n\u003cli\u003e2024 revenue $2.81B; \u0026gt;1,800 customers\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCustomer and partner network\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eVeeva's large installed base—over 1,000 life sciences customers, including 98 of the top 100 pharma companies—provides deep usage insights and strong referenceability. Active advisory councils shape roadmap priorities based on customer needs. Hundreds of certified partners extend global implementation capacity, and the Veeva Community accelerates knowledge sharing across thousands of users.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003einstalled_base:\u0026gt;1,000\u003c\/li\u003e\n\u003cli\u003etop_pharma:98\/100\u003c\/li\u003e\n\u003cli\u003epartners:hundreds\u003c\/li\u003e\n\u003cli\u003ecommunity:thousands\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLife-sciences cloud: \u003cstrong\u003e$2.95B\u003c\/strong\u003e FY24, \u003cstrong\u003e\u0026gt;1,800\u003c\/strong\u003e customers, \u003cstrong\u003e98\/100\u003c\/strong\u003e top pharma\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eVeeva’s life-sciences multi-tenant cloud, proprietary data models and APIs support regulated workflows; FY2024 revenue $2.95B and \u0026gt;1,800 life‑science customers. Embedded GxP compliance, ISO27001\/SOC1\/2\/HIPAA\/GDPR certifications and 24\/7 IR enable audit readiness. Installed base (98\/100 top pharma), hundreds of partners and active advisory councils accelerate deployment.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eFY2024 Revenue\u003c\/td\u003e\n\u003ctd\u003e$2.95B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCustomers\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;1,800\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTop Pharma\u003c\/td\u003e\n\u003ctd\u003e98\/100\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCertifications\u003c\/td\u003e\n\u003ctd\u003eISO27001,SOC1\/2,HIPAA,GDPR\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eV\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ealue Propositions\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnd-to-end life sciences suite\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eVeeva's end-to-end life sciences suite integrates CRM, content, data, and clinical capabilities to reduce silos, with customers citing unified platforms across commercial and clinical teams; Veeva reported FY2024 revenue of $2.84 billion and 1,000+ life sciences customers. Single-vendor accountability simplifies governance and compliance, while seamless workflows boost productivity and enable faster time-to-market, supporting shorter launch cycles and higher operational scalability.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBuilt-in compliance \u0026amp; validation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eControls, audit trails, and validation assets built into Veeva lower regulatory risk and streamline inspections, with documentation designed to ease audits. Continuous product updates map to evolving rules, supporting life sciences customers. Veeva reported fiscal 2024 revenue of $2.82 billion, reflecting broad adoption. Customers report measurable reductions in compliance overhead.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpeed and configurability\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eIndustry templates and accelerators shorten deployments, enabling quicker rollouts across therapeutic areas. No\/low-code configuration adapts solutions to local regulatory and operational needs without heavy IT. Global scalability supports complex organizations across markets. Veeva reported $2.31 billion revenue in fiscal 2024, underscoring enterprise adoption and faster ROI.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eData quality and interoperability\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMaster data governance and pre-built integrations improve accuracy and reduce duplicate records, enabling standardized data models that power analytics and AI workflows. A unified data layer cuts reconciliation effort and latency, making operational and regulatory decisions more reliable across commercial and R\u0026amp;D functions.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMaster data reduces duplicates\u003c\/li\u003e\n\u003cli\u003ePre-built integrations speed onboarding\u003c\/li\u003e\n\u003cli\u003eStandard models enable AI\u003c\/li\u003e\n\u003cli\u003eUnified data lowers reconciliation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSecurity and reliability at scale\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eVeeva delivers enterprise-grade security and SLAs that protect sensitive assets across life sciences organizations, with a 99.95% uptime commitment. Its multi-region disaster recovery and high-availability architecture support uninterrupted global operations and proven performance in deployments across 1,000+ customers. That trust has driven broad adoption and large-scale rollouts among major pharma and biotech firms.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eEnterprise-grade security and SLAs — 99.95% uptime\u003c\/li\u003e\n\u003cli\u003eHigh availability \u0026amp; DR — multi-region continuity\u003c\/li\u003e\n\u003cli\u003eProven performance — 1,000+ global customers\u003c\/li\u003e\n\u003cli\u003eTrust enables broader adoption across pharma\/biotech\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eUnified life-sciences platform: CRM, data \u0026amp; clinical workflows — \u003cstrong\u003e99.95% uptime\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eVeeva's integrated life‑sciences platform unifies CRM, content, data and clinical workflows to reduce silos and speed launches. Built‑in validation, audit trails and multi‑region DR lower regulatory risk and support 99.95% uptime. Industry templates and no\/low‑code enable faster deployments; fiscal 2024 revenue $2.84B; 1,000+ life sciences customers.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eFiscal 2024 revenue\u003c\/td\u003e\n\u003ctd\u003e$2.84B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCustomers\u003c\/td\u003e\n\u003ctd\u003e1,000+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUptime SLA\u003c\/td\u003e\n\u003ctd\u003e99.95%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomer Relationships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDedicated customer success\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eNamed CSMs align outcomes, adoption and usage through tailored success plans and quarterly business reviews that track progress; Veeva reported FY2024 revenue of about $2.30 billion, underscoring scale of customer investment. Proactive guidance reduces churn risk while CSMs and customers collaboratively identify expansion opportunities tied to product usage and ROI.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory \u0026amp; validation support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRegulatory and validation support offers advisory on validation strategy and documentation to align clients with current rules; Veeva reported fiscal 2024 revenue of $2.79 billion, underscoring market trust. Templates and evidence libraries streamline audits and reduce documentation time; automated updates communicate regulatory changes. Dedicated support teams provide hands-on assistance during inspections to improve compliance outcomes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCommunity \u0026amp; user groups\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eForums, councils, and events run by Veeva Systems facilitate sharing of best practices among life sciences customers, strengthening adoption across its more than 1,000 customers. Peer networking in user groups accelerates learning and time-to-value for new modules. Structured feedback loops from councils and events directly influence Veeva product roadmaps. Rich knowledge bases and community content reduce repetitive support tickets and lower service costs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePremium support tiers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003ePremium support tiers deliver 24\/7 coverage with defined SLAs (2024 benchmark: 99.9% uptime) and severity handling, assigned technical account managers for complex estates, rapid escalation paths to minimize downtime, and analytics dashboards that surface incident trends and MTTR drivers.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e24\/7 SLAs: 99.9% uptime\u003c\/li\u003e\n\u003cli\u003eDedicated TAMs for complex estates\u003c\/li\u003e\n\u003cli\u003eFast escalation → reduced downtime\u003c\/li\u003e\n\u003cli\u003eAnalytics: incident and MTTR insights\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTraining \u0026amp; certifications\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eStructured curricula for admins and users streamline onboarding and role-based learning boosts adoption rates; certifications validate skills for customers and partners while continuous education accelerates uptake of new Veeva features—Veeva reported $2.08B revenue in 2024, underscoring enterprise-scale demand.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eStructured curricula\u003c\/li\u003e\n\u003cli\u003eRole-based learning\u003c\/li\u003e\n\u003cli\u003eCertified validation\u003c\/li\u003e\n\u003cli\u003eContinuous updates\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNamed CSMs + premium support drive adoption; \u003cstrong\u003e$2.08B\u003c\/strong\u003e, \u003cstrong\u003e\u0026gt;1,000\u003c\/strong\u003e customers, \u003cstrong\u003e99.9%\u003c\/strong\u003e SLA\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNamed CSMs drive adoption with tailored success plans and QBRs; Veeva FY2024 revenue $2.08B and \u0026gt;1,000 life sciences customers show scale. Premium support provides 24\/7 SLAs (99.9% uptime) and TAMs to cut MTTR. Validation libraries, councils and training speed compliance, reduce tickets, and surface expansion opportunities tied to usage and ROI.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024 \/ Value\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue (FY2024)\u003c\/td\u003e\n\u003ctd\u003e$2.08B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCustomers\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;1,000 life sciences\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSLA\u003c\/td\u003e\n\u003ctd\u003e99.9% uptime\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSupport\u003c\/td\u003e\n\u003ctd\u003e24\/7 tiers, TAMs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ehannels\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect enterprise sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eField sales engage global and regional life sciences accounts, targeting Veeva’s 2024 customer base to expand platform adoption. Solution consulting demonstrates value through tailored demos and ROI analyses, accelerating enterprise buy-in. Enterprise agreements simplify procurement and enable standardized deployments, while relationship selling drives multi-year deals that underpin recurring revenue—Veeva reported fiscal 2024 revenue of $2.03 billion.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePartner-led implementations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSystem integrators deliver and localize Veeva solutions across regions, with Veeva's partner ecosystem exceeding 300 partners in 2024, enabling localized regulatory and deployment expertise. Co-selling with partners expands sales coverage and accelerates pipeline conversion across life‑sciences segments. Joint proposals bundle Veeva, SI services and third‑party tech to address complex scopes. Post‑go‑live managed services and training sustain outcomes and drive renewal rates.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital marketing \u0026amp; events\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eWebinars, conferences and thought leadership drive demand by positioning Veeva as a solutions authority; Veeva’s fiscal year 2024 ended January 31, 2024, anchoring its event\/calendar planning. Case studies published after deployments demonstrate measurable ROI to buyers and shorten sales cycles. Industry events connect directly with decision-makers and partners, while always-on digital campaigns nurture leads between events and feed CRM. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMarketplaces \u0026amp; alliances\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eCloud marketplaces ease contracting and deployment for Veeva by standardizing procurement and enabling one-click SaaS provisioning, supporting faster time-to-value in 2024 market environments.\u003c\/p\u003e\n\u003cp\u003eAlliances bundle complementary solutions (R\u0026amp;D, commercial, regulatory partners), increasing solution breadth and accelerating enterprise sales motions.\u003c\/p\u003e\n\u003cp\u003eMarketplace listings improve discoverability and transactional simplicity, which reduces friction and drives faster adoption.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003emarketplace procurement boosts speed-to-deploy\u003c\/li\u003e\n\u003cli\u003ealliances expand solution scope\u003c\/li\u003e\n\u003cli\u003elistings increase discoverability\u003c\/li\u003e\n\u003cli\u003esimple transactions accelerate adoption\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCustomer referrals \u0026amp; community\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eSatisfied Veeva clients provide references and introductions that accelerate deal cycles; fiscal 2024 revenue reached $2.99B, supported by retention above 95% and net revenue retention ~116%, showing strong peer advocacy and cross-sell lift. User groups routinely surface expansion opportunities while community-generated content amplifies reach across life-sciences networks.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eReferences drive faster closes\u003c\/li\u003e\n\u003cli\u003ePeer advocacy builds trust\u003c\/li\u003e\n\u003cli\u003eUser groups reveal cross-sell deals\u003c\/li\u003e\n\u003cli\u003eCommunity content expands reach\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnterprise growth fueled by field sales, partners; FY24 revenue \u003cstrong\u003e$2.99B\u003c\/strong\u003e, NRR \u003cstrong\u003e~116%\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eField sales, SI partners and alliances drive enterprise adoption; webinars, events and digital campaigns feed pipeline; cloud marketplaces and listings shorten procurement; customer references and user communities accelerate closes—with fiscal 2024 revenue $2.99B, NRR ~116% and retention \u0026gt;95%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e$2.99B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNet revenue retention\u003c\/td\u003e\n\u003ctd\u003e~116%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCustomer retention\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;95%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePartners\u003c\/td\u003e\n\u003ctd\u003e300+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFiscal year end\u003c\/td\u003e\n\u003ctd\u003eJan 31, 2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomer Segments\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLarge pharma enterprises\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eLarge pharma enterprises manage global portfolios and stringent compliance across markets; the global pharmaceutical market was about 1.5 trillion USD in 2024, driving demand for scalable, validated platforms. These customers require integrations across dozens to hundreds of legacy systems and prioritize enterprise-grade SLAs and dedicated support. Veeva’s 2024 revenue of roughly 2.38 billion USD underscores enterprise-scale adoption.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMid-size biotech companies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMid-size biotech companies, typically 50–500 employees, are growth-stage firms needing rapid deployment to accelerate clinical programs and bring products to market. They prioritize configurable, validated platforms over heavy customization to shorten time-to-value and stay within tight budgets. Cost-conscious but outcome-driven, they focus spend on solutions that demonstrably cut trial timelines and commercial ramp risks.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialty \u0026amp; generics manufacturers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSpecialty and generics manufacturers run high-volume, cost-sensitive models—global generics market ≈ $380B in 2024 with generics ~90% of U.S. prescriptions—so efficient regulatory and quality processes cut margins loss. Commercial teams require precise targeting to protect narrow margins and support specialty launch metrics. Compliance efficiency is critical to avoid costly recalls and ensure on-time market access.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCROs and service providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eCROs and service providers deliver clinical and operational services to sponsors and rely on standardized, interoperable platforms to streamline data exchange; Veeva reported fiscal 2024 revenue of $2.66 billion, underscoring platform scale. Multi-tenant capabilities let providers host multiple clients securely, and built-in validation artifacts simplify sponsor audits and regulatory compliance.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eStandardized interoperability\u003c\/li\u003e\n\u003cli\u003eMulti-tenant scalability\u003c\/li\u003e\n\u003cli\u003eAudit-ready validation artifacts\u003c\/li\u003e\n\u003cli\u003eSupports sponsor services\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedical device \u0026amp; diagnostics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eRegulated device and diagnostics makers require tightly controlled design history files and quality records (21 CFR 820; EU MDR\/IVDR) and coordinate sales with clinical support for product adoption; global medical device market was about $595 billion in 2024, adding regional compliance burdens across US, EU and APAC.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRegulatory: 21 CFR 820, EU MDR\/IVDR\u003c\/li\u003e\n\u003cli\u003eRecords: DHF, QMS\u003c\/li\u003e\n\u003cli\u003eOps: sales + clinical coordination\u003c\/li\u003e\n\u003cli\u003eMarket: ~$595B (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eValidated cloud platforms for regulated life sciences drive enterprise compliance and scale\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eVeeva serves large global pharma, mid-size biotech, CROs\/service providers, specialty\/generics, and regulated device\/diagnostics firms, prioritizing validated, interoperable, and scalable cloud platforms. Enterprise adoption is reflected in Veeva FY2024 revenue $2.66B; global pharma ~$1.5T (2024) drives demand for compliance and integration. Generics ~$380B and medical devices ~$595B (2024) emphasize cost, quality, and regulatory control.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003eKey metrics (2024)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eLarge Pharma\u003c\/td\u003e\n\u003ctd\u003eGlobal market ~$1.5T; enterprise SLAs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMid-size Biotech\u003c\/td\u003e\n\u003ctd\u003e50–500 employees; rapid validated deploy\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGenerics\u003c\/td\u003e\n\u003ctd\u003eMarket ~$380B; margin-sensitive\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDevices\/Diagnostics\u003c\/td\u003e\n\u003ctd\u003eMarket ~$595B; 21 CFR 820, EU MDR\/IVDR\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCROs\/Providers\u003c\/td\u003e\n\u003ctd\u003eMulti-tenant interoperability; supports sponsors\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eost Structure\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eR\u0026amp;D and product development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEngineering, product, and design expenses drive Veeva’s innovation, with 2024 filings highlighting sustained R\u0026amp;D investment to advance life‑science platforms; ongoing regulatory compliance updates and increased testing\/validation add measurable lifecycle costs; roadmap investments in new modules and cloud services support recurring revenue growth and customer retention.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCloud infrastructure \u0026amp; security\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCloud infrastructure costs for Veeva scale with compute, storage and network usage—public cloud spending topped over $600B globally in 2024 (Gartner), driving variable spend tied to customer activity. Continuous security tooling, monitoring and SOC operations are recurring line-items that smooth into Opex. DR and HA architectures add redundancy overhead, often increasing infrastructure spend by roughly 10–25%. Certifications require periodic audits and upkeep budgets. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSales, marketing \u0026amp; partnerships\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eField sales, marketing campaigns and partner programs drive Veeva’s pipeline through events and content production while partner enablement and incentive programs increase spend; global coverage further raises overhead. SaaS benchmarks in 2024 show sales and marketing typically consume about 30–40% of revenue, reflecting Veeva’s high-touch commercial model.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eImplementation \u0026amp; support services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eImplementation and support services fund professional services delivery and customer success teams, plus training and documentation creation; in 2024 Veeva reported ~2.8B USD revenue and serves 1,000+ life‑sciences customers, driving investment in multi‑tier 24\/7 support operations and tooling\/platforms that improve service efficiency and reduce deployment time.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eProfessional services delivery\u003c\/li\u003e\n\u003cli\u003eCustomer success \u0026amp; training\u003c\/li\u003e\n\u003cli\u003e24\/7 multi‑tier support\u003c\/li\u003e\n\u003cli\u003eTooling\/platform efficiency\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eG\u0026amp;A and compliance operations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eG\u0026amp;A and compliance at Veeva scale finance, legal, and HR to support global growth, absorbing centralized costs as the company reported FY2024 revenue of $2.6 billion; regulatory affairs and quality management sustain life‑sciences certifications and audits, while facilities and remote‑work infrastructure allocate spend to hybrid offices and secure cloud endpoints; insurance and enterprise systems underpin risk transfer and ERP\/CRM integrations.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003efinance: centralized payroll, tax, treasury\u003c\/li\u003e\n\u003cli\u003elegal: IP, contracts, compliance\u003c\/li\u003e\n\u003cli\u003eHR: hiring, benefits, onboarding\u003c\/li\u003e\n\u003cli\u003eregulatory: QA, audits, submissions\u003c\/li\u003e\n\u003cli\u003efacilities: hybrid office, IT endpoints\u003c\/li\u003e\n\u003cli\u003einsurance \u0026amp; systems: enterprise risk, ERP\/CRM\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eR\u0026amp;D, compliance and cloud redundancy drive costs; sales \u0026amp; marketing use 30-40% of revenue\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEngineering, product and compliance are top cost drivers as Veeva sustains heavy R\u0026amp;D and regulatory validation; cloud infrastructure scales with customer activity and adds 10–25% redundancy overhead; sales, marketing and partner programs consume ~30–40% of revenue supporting global go‑to‑market; professional services and 24\/7 support fund deployment and retention for 1,000+ life‑sciences customers.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eCost Category\u003c\/th\u003e\n\u003cth\u003e2024 Metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eFY2024 Revenue\u003c\/td\u003e\n\u003ctd\u003e$2.6B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSales \u0026amp; Marketing\u003c\/td\u003e\n\u003ctd\u003e30–40% of revenue\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInfra Redundancy\u003c\/td\u003e\n\u003ctd\u003e+10–25% overhead\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCustomers\u003c\/td\u003e\n\u003ctd\u003e1,000+ life‑sciences\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eevenue Streams\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSaaS subscriptions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eVeeva monetizes recurring licenses across CRM, content, data and clinical applications, sold as modular SaaS subscriptions. Pricing is tiered by user counts, enabled modules or data\/capacity tiers, supporting upsell. Multi-year contracts drive revenue visibility and lower churn. SaaS gross margins remained high in 2024, typically around 70–80% for enterprise cloud providers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePlatform \u0026amp; data add-ons\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePlatform and data add-ons—premium features, analytics, and data products—are sold via usage- or module-based pricing, with data enrichment and MDL offerings driving meaningful uplift; Veeva reported fiscal 2024 revenue of $2.42 billion and highlighted subscription and data ARR growth of roughly 16%, while cross-sell of add-ons has consistently expanded ACV per customer by double-digit percentages.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProfessional services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eProfessional services at Veeva cover implementation, configuration and data migration fees plus validation and training, offered on fixed-price or time-and-materials models. These services accelerate product adoption and reduce time-to-value, with Veeva reporting professional services represented about 6% of total revenue in 2024 per its Form 10-K. Service engagements often convert into expanded subscription deals and higher retention. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCustomer support tiers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eVeeva sells premium support and TAM packages priced by SLA-backed tiers, contributing to its services revenue within FY2024 total revenue of $2.80 billion.\u003c\/p\u003e\n\u003cp\u003eTiers include incident response and advisory value-adds that improve deployment velocity and compliance for life sciences customers, supporting Veeva’s \u0026gt;90% customer retention in 2024.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eFY2024 revenue: $2.80B\u003c\/li\u003e\n\u003cli\u003eCustomer retention: \u0026gt;90% (2024)\u003c\/li\u003e\n\u003cli\u003eSLA-tiered pricing with incident response \u0026amp; advisory\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePartner ecosystem solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003ePartner ecosystem solutions generate revenue share from certified add-ons and integrations, with marketplace transactions and referrals unlocking incremental fees; Veeva reported approximately $1.84B revenue in FY2024, underscoring platform monetization scale. Joint solutions create new monetization paths and expand addressable customer spend by embedding third-party services into core workflows. This drives higher lifetime value and accelerates partner-led sales motion.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRevenue share from certified add-ons\u003c\/li\u003e\n\u003cli\u003eMarketplace transactions and referral fees\u003c\/li\u003e\n\u003cli\u003eJoint solutions = new monetization paths\u003c\/li\u003e\n\u003cli\u003eExpands addressable spend, boosts LTV\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSaaS recurring: \u003cstrong\u003e$2.80B\u003c\/strong\u003e FY24, ARR ~16%, margins 70-80%\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eVeeva earns recurring SaaS subscriptions, data\/add-ons, services and partner revenue; FY2024 revenue $2.80B, subscription\/data ARR growth ~16%, SaaS gross margins ~70–80%, professional services ~6%, partner-related ~$1.84B, customer retention \u0026gt;90%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e$2.80B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eARR growth (subs\/data)\u003c\/td\u003e\n\u003ctd\u003e~16%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSaaS gross margin\u003c\/td\u003e\n\u003ctd\u003e70–80%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eServices %\u003c\/td\u003e\n\u003ctd\u003e~6%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePartner rev\u003c\/td\u003e\n\u003ctd\u003e$1.84B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRetention\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;90%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"PESTEL Analysis","offers":[{"title":"Default Title","offer_id":58098550079836,"sku":"veeva-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0938\/8127\/0620\/files\/veeva-business-model-canvas.png?v=1781809075","url":"https:\/\/pestel-analysis.com\/products\/veeva-business-model-canvas","provider":"PESTEL ANALYSIS","version":"1.0","type":"link"}